RESERVED AREA     |

News

Troina Meeting on Genetics of Neurodevelopmental Disorders

14th Troina Meeting on Genetics of Neurodevelopmental Disorders

News

Troina Meeting on Genetics of Neurodevelopmental Disorders

Meeting: 14th Troina Meeting on Genetics of Neurodevelopmental Disorders, April 4th-6th, 2019
Participant: Natália Oliva Teles – Management Committee Member (Substitute)
Affiliations: 1-Centro de Genética Médica Doutor Jacinto Magalhães/Centro Hospitalar Universitário do Porto, E.P.E.; 2-Universidade do Porto, Unidade Multidisciplinar de Investigação Biomédica (UMIB/ICBAS,UP); 3- Universidade do Porto, Faculdade de Medicina, MEDCIDS, PORTUGAL

On the 4th April 2019, on the Short Communications Session 2, 17.15-17.30, Natália Oliva Teles has presented the following work, entitled: Loss of amplification variation observed in six families detected in 22q11.2 region by multiplex ligation-dependent probe amplification, as shown below.

Apart from having made this presentation, while divulging MINDDS and COST ACTION 16210 she had the opportunity of meeting some of the best world experts in Autism Spectrum Disorders (France, Canada, Austria, Italy), Fragile-X Syndrome (Belgium, USA, France, Italy, Portugal), Intellectual Disability (The Netherlands, Saudi Arabia, USA, Italy, Epilepsy (USA, Germany, Italy, The Netherlands). The Conference proved to be remarkable in terms of high-level quality of presentations and knowledge of the respective fields. Also, it became clear that some of the very best research is done in the Laboratories of most of the presenters, which constitutes a good asset for eventual future collaborations with this COST ACTION Members. Therefore, this Meeting is highly recommended for future visits of this COST ACTION.

Porto, CGMJM/CHUP,E.P.E., 15.04.2019

Natália Oliva Teles – Management Committee Member (Substitute) – COST ACTION 16210

MINDDS

Understanding rare neurodevelopmental disorders (NDD) has the potential drive major new therapies for the common NDD of schizophrenia and Autism Spectrum Disorder (ASD).